Ieramilimab
Product Specifications
Target
LAG-3
Related Pathways
Immunology/Inflammation
Purity
0.978
Bioactivity
Ieramilimab (LAG525) is a humanized antibody targeting LAG-3 with potential anticancer activity, blocking its interaction with MHC-II molecules by binding to LAG-3.Pranlukast hemihydrate can be used to study malignant tumors.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
819619 1 Card (1 Panel (s) x 1 Pack)
PIC M012-Dia 400-PP-CRD/1 Safety & Regulatory Compliance Signs (No Adhesive)
Sign In for Pricing
View Details